Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

"...$5B figure is a very nice baseline!"

It's fun to dream! I read somewhere that peak sales for Xiidra are expected to be $1.4B (now 400M) annually.

If true, then NVS just paid approximately 3.8 times peak sales. Wonder what the 400 employees that go with the deal actually do all day?

If VCS for LN is conservatively estimated to generate $1.3B peak sales, then that's a $4B value at just over 3 times peak sales.

If VOS is worth $5B and Aurinia gets all the money that translates into a $81 stock value for AUPH, fully diluted as of today.